Windsor Group LTD Dexcom Inc Transaction History

Windsor Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$94.08 - $130.2 $59,740 - $82,677	-635 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$129.87 - $162.82 $389 - $488	-3 Reduced 0.47%	635 $325,000
Q3 2021 Oct 12, 2021	BUY	$106.71 - $143.18 $1,387 - $1,861	13 Added 2.08%	638 $351,000
Q2 2021 Jul 26, 2021	BUY	$80.99 - $107.93 $50,618 - $67,456	625 New	625 $267,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Windsor Group LTD, based on Form 13F filings with the SEC.

Stay updated on Windsor Group LTD with notifications on news.